Item 8.01 Other Events.

On May 2, 2022, DBV Technologies S.A. (the "Company") entered into a Sales Agreement (the "Sales Agreement") with Jefferies LLC ("Jefferies") with respect to an equity offering program (the "Offering") under which the Company may offer and sell American Depositary Shares ("ADS"), each ADS representing one-half of one ordinary share, from time to time, through Jefferies as its sales agent. Pursuant to the Sales Agreement and the prospectus contained in the registration statement on Form S-3 described below, the Company may offer and sell ADSs having an aggregate offering price of up to $100.0 million (subject to French regulatory limits).

The issuance and sale, if any, of the ADSs by the Company under the Sales Agreement will be made pursuant to the Company's effective registration statement on Form S-3 (Registration Statement No. 333-257569).

Sales of the Company's ADSs, if any, in the Offering may be made in sales deemed to be an "at the market offering" as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), from time to time. Jefferies is not required to sell any specific number or dollar amount of securities, but will act as sales agent and use commercially reasonable efforts to arrange on the Company's behalf for the sale of all ADSs requested to be sold by the Company, consistent with Jefferies' normal sales and trading practices. There is no arrangement for funds to be received in any escrow, trust or similar arrangement. Sales may also be conducted, with the Company's consent, in negotiated transactions.

The Company will pay Jefferies a commission equal to three percent (3.0%) of the gross sales price per ADS sold through Jefferies under the Sales Agreement and also has agreed to provide indemnification and contribution to Jefferies with respect to certain liabilities, including liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended (the "Exchange Act").

The Company is not obligated to make any sales of ADSs pursuant to the Sales Agreement. The Offering pursuant to the Sales Agreement will terminate upon the earlier of (i) the sale of all ADSs subject to the Sales Agreement and (ii) the termination of the Sales Agreement as permitted therein. Each of the Company and Jefferies may terminate the Sales Agreement at any time upon ten trading days' prior notice.

The foregoing description of the Sales Agreement is not complete and is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is filed herewith as Exhibit 1.1 and is incorporated herein by reference. A copy of the legal opinion of McDermott Will & Emery AARPI, the Company's French counsel, relating to the legality of the issuance of the ordinary shares in the Offering is attached as Exhibit 5.1 hereto.

This Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein.

The Company issued a press release announcing the establishment of the Offering on May 2, 2022. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit     Description

 1.1          Sales Agreement, dated as of May 2, 2022, by and between DBV
            Technologies S.A. and Jefferies LLC.

 5.1          Opinion of McDermott Will & Emery AARPI.

23.1          Consent of McDermott Will & Emery AARPI (included in Exhibit 5.1).


99.1          Press Release of DBV Technologies S.A. dated May 2, 2022, furnished
            herewith

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses